In the case of the three genetic variants identified here, related studies have revealed that the 3 variants lead to inactivation of SHP-2, instability of conformation, and enhancement of SHP-2 function, resulting in the occurrence of Noonan syndrome [8–10]. The gene discussed is PTPN11; the disease is Noonan syndrome.